AptarGroup, Inc. (ATR) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $131.01. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ATR = $204.50 (+56.1% from the current price, the stock appears undervalued). Analyst consensus target is ATR = $170 (+29.5% upside).
Valuation: ATR trades at a trailing Price-to-Earnings (P/E) of 21.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.36.
Financials: revenue is $3.8B, +4.4%/yr average growth. Net income is $393M, growing at +18.5%/yr. Net profit margin is 10.4% (healthy). Gross margin is 29.6% (-5.4 pp trend).
Balance sheet: total debt is $1.5B against $2.7B equity (Debt-to-Equity (D/E) ratio 0.57, moderate). Current ratio is 1.62 (strong liquidity). Debt-to-assets is 29.1%. Total assets: $5.3B.
Analyst outlook: 8 / 18 analysts rate ATR as buy (44%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 73/100 (Pass), Growth 63/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 38/100 (Fail), Future 46/100 (Partial), Income 55/100 (Partial).
